• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD Q-SYTE LUER ACCESS SPLIT SEPTUM; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD Q-SYTE LUER ACCESS SPLIT SEPTUM; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385100
Device Problem Defective Device (2588)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/04/2023
Event Type  malfunction  
Event Description
It was reported that the bd q-syte luer access split septum experienced damage of the needle-free joint.The following information was provided by the initial reporter, translated from chinese to english: the surface collapse of needle-free joint in use requires green claim and complaint reply letter.
 
Manufacturer Narrative
Initial reporter phone #: (b)(6).A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the bd q-syte luer access split septum experienced damage of the needle-free joint.The following information was provided by the initial reporter, translated from chinese to english: the surface collapse of needle-free joint in use requires green claim and complaint reply letter.
 
Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval: yes.D10: returned to manufacturer on: 22-may-2023.H6: investigation summary: our quality engineer inspected the sample and photographs submitted for evaluation.Bd received one used q-syte unit with no product documentation to indicate the reference or lot number.The photos are representative of what was returned and do not provide any additional evidence that isn¿t already covered by the physical sample evaluation.A gross visual inspection of the returned unit found that a portion the septum top disk was pushed in.Further inspection found that the portions of the top disk where the septum was not pushed in were still properly adhered.The unit was microscopically inspected.Inspection found that adhesive residue was present along the entire rim of the top body and on the underside of the top disk, indicating that adequate adhesion of the septum had been achieved during manufacture of the device.Although the reported issue was confirmed, it could not be determined if the damage resulted from the manufacturing of the device or from the user environment.During manufacturing, low bond strength (or insufficient adhesive), septum misorientation, damage to the top body of the q-syte, and damaged tooling may result in the septum being pushed in.Operator-controlled checks for bond strength and septum damage are performed to mitigate the risk from this type of defect.Additionally, during use, a pushed in septum can occur due to excessive actuations and extraneous force.Given that the sample was returned in a used state, this scenario cannot be ruled out.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE LUER ACCESS SPLIT SEPTUM
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17014891
MDR Text Key316440479
Report Number1710034-2023-00576
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00382903851003
UDI-Public00382903851003
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K013621
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number385100
Device Catalogue Number385100
Device Lot Number1293672
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/04/2023
Initial Date FDA Received05/26/2023
Supplement Dates Manufacturer Received07/02/2023
Supplement Dates FDA Received07/17/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-